Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression

Han and Deng et al. show the relationship between follicular lymphoma tumor B-cell mutations and expression patterns, and associations with characteristics of tumor-infiltrating T-cell subsets.

[1]  N. Almog,et al.  Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. , 2021, Cancer cell.

[2]  I. Wistuba,et al.  Multiplex Immunofluorescence Tyramide Signal Amplification for Immune Cell Profiling of Paraffin-Embedded Tumor Tissues , 2021, Frontiers in Molecular Biosciences.

[3]  Hanlee P. Ji,et al.  Single Cell Analysis Can Define Distinct Evolution of Tumor Sites in Follicular Lymphoma. , 2021, Blood.

[4]  J. Leonard,et al.  Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures. , 2021, Cancer discovery.

[5]  Ryan D. Chow,et al.  CRISPR-GEMM pooled mutagenic screening identifies KMT2D as a major modulator of immune checkpoint blockade. , 2020, Cancer discovery.

[6]  M. Lanuti,et al.  Abstract 853: Novel machine learning based deconvolution algorithm results in accurate description of tumor microenvironment from bulk RNAseq , 2020 .

[7]  S. Fröhling,et al.  Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels , 2020, Nature Cell Biology.

[8]  Chun Jimmie Ye,et al.  Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer , 2020, Cell.

[9]  Michael R. Green,et al.  The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing , 2020, Nature Cancer.

[10]  Mei Jiang,et al.  Procedural Requirements and Recommendations for Multiplex Immunofluorescence Tyramide Signal Amplification Assays to Support Translational Oncology Studies , 2020, Cancers.

[11]  W. Klapper,et al.  Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Mariella G. Filbin,et al.  An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma , 2019, Cell.

[13]  Michael R. Green,et al.  Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma , 2019, bioRxiv.

[14]  Fabian J Theis,et al.  Current best practices in single‐cell RNA‐seq analysis: a tutorial , 2019, Molecular systems biology.

[15]  Ash A. Alizadeh,et al.  Determining cell-type abundance and expression from bulk tissues with digital cytometry , 2019, Nature Biotechnology.

[16]  Noemi Andor,et al.  Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints. , 2019, Blood.

[17]  A. López-Guillermo,et al.  Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population , 2019, British journal of haematology.

[18]  Ryan D. Morin,et al.  Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition. , 2019, Cancer discovery.

[19]  Michael R. Green,et al.  Selective inhibition of HDAC3 targets synthetic vulnerabilities and activates immune surveillance in lymphoma , 2019, bioRxiv.

[20]  E. Giné,et al.  Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era , 2018, British journal of haematology.

[21]  Vincent A. Traag,et al.  From Louvain to Leiden: guaranteeing well-connected communities , 2018, Scientific Reports.

[22]  J. Leonard,et al.  Novel immunotherapy approaches to follicular lymphoma. , 2018, Hematology. American Society of Hematology. Education Program.

[23]  Fan Zhang,et al.  Fast, sensitive, and accurate integration of single cell data with Harmony , 2018, bioRxiv.

[24]  Christoph Hafemeister,et al.  Comprehensive integration of single cell data , 2018, bioRxiv.

[25]  Monika S. Kowalczyk,et al.  A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade , 2018, Cell.

[26]  Paul J. Hoover,et al.  Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma , 2018, Cell.

[27]  B. Nadel,et al.  Human germinal center transcriptional programs are de-synchronized in B cell lymphoma , 2018, Nature Immunology.

[28]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[29]  Leland McInnes,et al.  UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction , 2018, ArXiv.

[30]  Michael R. Green,et al.  Chromatin modifying gene mutations in follicular lymphoma. , 2018, Blood.

[31]  K. Savage,et al.  Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Robert Kridel,et al.  Pathogenesis of follicular lymphoma. , 2017, Best practice & research. Clinical haematology.

[33]  Salles,et al.  A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts , 2018 .

[34]  Fabian J Theis,et al.  SCANPY: large-scale single-cell gene expression data analysis , 2018, Genome Biology.

[35]  G. Lenz,et al.  Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Ryan Emerson,et al.  TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence. , 2017, Cancer discovery.

[37]  M. Manz,et al.  Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth , 2017, Proceedings of the National Academy of Sciences.

[38]  Boxi Kang,et al.  Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing , 2017, Cell.

[39]  D. Speiser,et al.  Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data , 2017, bioRxiv.

[40]  Ash A. Alizadeh,et al.  Antigen Presentation Profiling Reveals Recognition of Lymphoma Immunoglobulin Neoantigens , 2017, Nature.

[41]  S. Kent,et al.  Cytotoxic CD4 T Cells—Friend or Foe during Viral Infection? , 2017, Front. Immunol..

[42]  O. Elemento,et al.  CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas. , 2017, Cancer discovery.

[43]  Ali Bashashati,et al.  Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study , 2016, PLoS medicine.

[44]  Lior Pachter,et al.  Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.

[45]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[46]  Robert Kridel,et al.  Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. , 2015, The Lancet. Oncology.

[47]  E. Komech,et al.  tcR: an R package for T cell receptor repertoire advanced data analysis , 2015, BMC Bioinformatics.

[48]  Ash A. Alizadeh,et al.  Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation , 2015, Proceedings of the National Academy of Sciences.

[49]  Steven H. Kleinstein,et al.  B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes , 2014, Science Translational Medicine.

[50]  Ash A. Alizadeh,et al.  Common progenitor cells in mature B-cell malignancies: implications for therapy , 2014, Current opinion in hematology.

[51]  Chris Sander,et al.  Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy , 2014, The Journal of experimental medicine.

[52]  Motohiko Tanino,et al.  Duodenal follicular lymphoma: Comprehensive gene expression analysis with insights into pathogenesis , 2014, Cancer science.

[53]  W. Chan,et al.  EZH2 Mutations in Follicular Lymphoma from Different Ethnic Groups and Associated Gene Expression Alterations , 2014, Clinical Cancer Research.

[54]  A. Rosenwald,et al.  Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma. , 2014, Blood.

[55]  Michael R. Green,et al.  Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. , 2013, The Journal of clinical investigation.

[56]  Ning Ma,et al.  IgBLAST: an immunoglobulin variable domain sequence analysis tool , 2013, Nucleic Acids Res..

[57]  Heng Li.  Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[58]  J. Allison,et al.  Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin , 2012, The Journal of experimental medicine.

[59]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[60]  R. Spang,et al.  Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing , 2012, Nature Genetics.

[61]  J. Wolchok,et al.  Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype , 2012, The Journal of experimental medicine.

[62]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[63]  Govind Bhagat,et al.  Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. , 2011, Cancer cell.

[64]  J. Martinez-Climent,et al.  PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma. , 2011, Blood.

[65]  Steven J. M. Jones,et al.  MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers , 2011, Nature.

[66]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[67]  L. Staudt,et al.  Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. , 2007, Blood.

[68]  Emily H Turner,et al.  Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes , 2009, Nature.

[69]  L. Staudt,et al.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.

[70]  J. Teruya-Feldstein,et al.  Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma. , 2002, Human pathology.